Causes, prevention, and management of diabetes-related foot ulcers
- PMID: 38824929
- DOI: 10.1016/S2213-8587(24)00110-4
Causes, prevention, and management of diabetes-related foot ulcers
Abstract
In this Review, we aim to complement the 2023 update of the guidelines of the International Working Group on the Diabetic Foot. We highlight the complexity of the pathological processes that underlie diabetes-related foot ulceration (DFU) and draw attention to the potential implications for clinical management and outcome. Variation observed in the incidence and outcome of DFUs in different communities might result from differences in study populations and the accessibility of care. Comparing differences in incidence, management, and outcome of DFUs in different communities is an essential component of the quality of disease care. Additionally, these comparisons can also highlight the relationship between DFU incidence, management, and outcome and the structure of local clinical services and the availability of staff with the necessary skills. The clinical outcome is, however, also dependent on the availability of multidisciplinary care and the ability of people with DFUs to gain access to that care.
Copyright © 2024 Published by Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.
Conflict of interest statement
Declaration of interests ES has received payment or honoraria for lectures from AdvanzPharma, Merck Sharp and Dohme, Pfizer, Shionogi, Menarini, and BioMérieux; has received support for attending meetings or travel from AdvanzPharma, Merck Sharp and Dohme, Pfizer, Shionogi, Menarini, and BioMérieux; has participated on the data safety monitoring board or advisory board for AdvanzPharma, Debiopharm, and MicuRx; is an editorial board member for IWGDF; and is chair of the National Diabetes Foot Audit England and Wales. EJB reports grant funding from the National Institutes of Health and US Department of Veterans Affairs; payment or honoraria for lectures, presentations, speakers bureaus, or educational events; support for attending meetings or travel from the Korean Diabetes Association, International Society for the Diabetic Foot Diabetes Association of the ROC (Taiwan), and the American Diabetes Association. FG has received grant funding from the National Institute for Healthcare Research; is an editorial board member of the IWGDF; and is chair for the National Diabetes Foot Audit England and Wales. RF is co-chair for the peripheral artery disease working group of the IWGDF. All other authors declare no competing interests.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
